Aspirin use and potential mechanisms for colorectal cancer prevention.
Open Access
- 15 September 1997
- journal article
- review article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 100 (6), 1325-1329
- https://doi.org/10.1172/jci119651
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumorsGastroenterology, 1996
- Prostaglandin endoperoxide synthase: why two isoforms?American Journal of Physiology-Gastrointestinal and Liver Physiology, 1996
- Nonsteroidal Antiinflammatory Drugs Inhibit the Proliferation of Colon Adenocarcinoma Cells: Effects on Cell Cycle and ApoptosisExperimental Cell Research, 1996
- Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2Cell, 1995
- Aspirin and the Risk of Colorectal Cancer in WomenNew England Journal of Medicine, 1995
- Expression of cyclooxygenase-1 and -2 in human colorectal cancer.1995
- The role of nonsteroidal anti-inflammatory drugs in colorectal cancer preventionEuropean Journal Of Cancer, 1995
- Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis.1995
- Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer.1995
- Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomasGastroenterology, 1994